Talis Biomedical Corporation (TLIS)
OTCMKTS · Delayed Price · Currency is USD
1.500
0.00 (0.00%)
Aug 14, 2025, 8:00 PM EDT
Talis Biomedical Market Cap
Talis Biomedical has a market cap or net worth of $2.73 million as of August 15, 2025. Its market cap has decreased by -82.96% in one year.
Market Cap
2.73M
Enterprise Value
-38.33M
Revenue
408.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.50
Market Cap Chart
Since February 12, 2021, Talis Biomedical's market cap has decreased from 652.79M to 2.73M, a decrease of -99.58%. That is a compound annual growth rate of -70.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 2.73M | -14.72% |
| Dec 31, 2024 | 3.21M | -76.37% |
| Dec 29, 2023 | 13.57M | 13.66% |
| Dec 30, 2022 | 11.94M | -88.68% |
| Dec 31, 2021 | 105.42M | -83.85% |
| Feb 12, 2021 | 652.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 781.22M |
| Tian'an Technology Group | 628.15M |
| Glass House Brands | 606.72M |
| Elite Pharmaceuticals | 567.29M |
| American Oncology Network | 389.51M |
| Northwest Biotherapeutics | 351.78M |
| CytoDyn | 336.73M |